Company / Financials
BIOFORCE NANOSCIENCES HOLDINGS, INC. Financials
FY2018-FY2020 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableRevenue
-
FY2020
Net Income
-$158.4M
FY2020 · -340285.4% YoY
Profit Margin
-
FY2020 · net income / revenue
ROE
-
FY2020 · return on equity
Total Assets
$39.9K
FY2020
Total Debt
-
FY2020
Equity
-$359.9K
FY2020
ROA
-397362.5%
FY2020 · return on assets
Statement paths
Financial highlights
Key Data Points
- Altman Z-Score -3388.70 (distress zone, below 1.23 threshold)
- Piotroski F-Score: 1/9 criteria passed
- Cash-backed earnings: Operating cash flow exceeds net income
Data sourced from SEC EDGAR filings. Not investment advice.
Metric history
Revenue HistoryTotal revenue from operations-Net Income HistoryProfit after all expenses and taxes-$158.4M-340285.4% YoYGross Profit HistoryRevenue minus cost of goods sold-Cost of Revenue HistoryDirect costs of producing goods and services sold-Operating Income HistoryProfit from core business operations before interest and taxes-SG&A Expense HistorySelling, general, and administrative expenses$81.0K+59.2% YoYIncome Tax HistoryTotal income tax expense-EPS (Diluted) HistoryDiluted earnings per share including stock options and convertibles$0.00Shares Outstanding HistoryWeighted average diluted shares outstanding15.3M+0.1% YoYTotal Assets HistoryTotal value of all assets owned$39.9K-32.3% YoY